Table 1.
Drug side effects resources.
Table 2.
Drug indication resources.
Figure 1.
Construction of drug network using side effects.
Table 3.
The 2×2 contingency table of drug A and indication i.
Figure 2.
The trends of covered drugs and drug-drug pairs that share the same terms in the MeSH hierarchy.
Table 4.
Top 10 ATC therapeutic categories with NDCG@5≥0.7.
Table 5.
Prediction performance of the 1234 drugs in different indication range (number of network drugs approved for an indication).
Table 6.
Predicted results with evidence supported at an EASE score≤10−5.
Figure 3.
Each node represents a drug. Drugs approved for pain management are marked in yellow. Drugs approved for rheumatoid arthritis therapy are marked in purple.
Figure 4.
Each node represents a drug. Drugs approved for the treatment of Parkinson's disease are marked in orange. Drugs approved for rheumatoid arthritis therapy are marked in blue.
Figure 5.
Each node represents a drug. Drugs approved for the treatment of Parkinson 's disease are marked in orange. Drugs approved for pain treatment are marked in blue.
Table 7.
The similarity of 98 SIDER drugs in test sample set with the drugs in the network.
Table 8.
Predicted drug-indication pairs of SIDER drugs.